Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai‐Dong Zhu, Jian Wang, Hai-Liang Li et al.|Signal Transduction and Targeted Therapy|2023Cited by 295
Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trialGao‐Jun Teng, Wei‐Fu Lv, Hai‐Dong Zhu et al.|International Journal of Surgery|2023Cited by 29